Thyroid Cancer

Expert discusses three promising options to treat patients with medullary thyroid cancer.

Patients who choose not to have their thyroid cancer treated often have feelings of anxiety and isolation, and are at a risk of disengaging from the health care system because they might not feel supported.

A recent study found that some late effects are more prevalent in patients who were diagnosed with thyroid cancer before 40 compared to those who were diagnosed at a later age.

Clinical trial enrollment must become speedier for patients with rare diseases such as anaplastic thyroid cancer, says Maria Cabanillas, M.D.

Encapsulated follicular variant of papillary thyroid cancer may actually not be cancer at all, according to Yuri E. Nikiforov.

Marcia S. Brose discusses Lenvima for patients with progressive radioactive iodine (RAI)-refractory differentiated thyroid cancer.

Nexavar and Lenvima have significantly altered the treatment paradigm for patients with advanced RAI-refractory differentiated thyroid cancer, with combination strategies hoping to further build upon this success.

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses how patients with cancer can cope with body image issues.

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body images among patients and survivors of head and neck cancer.

According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.

The FDA has granted approval to Lenvima (lenvatinib) as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), based on findings from the phase 3 SELECT trial.

With a deadline of April 14, the FDA will soon make its final approval decision on lenvatinib as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).

The Food and Drug Administration's calendar for making decisions on new cancer drugs and indications is taking shape for 2015, and the clock is ticking on at least 13 applications for novel agents and new therapeutic settings for existing drugs.

The latest in cancer prevention, diagnosis & treatment.

Researchers urge restraint when it comes to treating thyroid cancer in children.

Types of thyroid cancer.

Patients may be asked to take steps to deplete their body's natural store of iodine so the thyroid will more readily absorb the radioactive iodine treatment and maximize treatment effectiveness

Thyroid cancer's high survival rate masks the sometimes tricky tumor.

KRAS gene mutations are detected in various cancers, including colorectal.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.